Upgrade to SI Premium - Free Trial

Bio-Rad Labs (BIO) PT Lowered to $414 at RBC Capital

May 8, 2024 6:22 AM
RBC Capital analyst Conor McNamara lowered the price target on Bio-Rad Labs (NYSE: BIO) to $414.00 (from $420.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles